Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia ; volume:59 ; number:7 ; year:2021 ; pages:1331-1331 ; extent:01
Clinical chemistry and laboratory medicine ; 59, Heft 7 (2021), 1331-1331 (gesamt 01)
- Creator
-
Lévy, Pacifique
Hamdi, Safouane
Guibourdenche, Jean
Haguet, Marie Clothilde
Bailleul, Sophie
Lefèvre, Guillaume
- DOI
-
10.1515/cclm-2021-0465
- URN
-
urn:nbn:de:101:1-2022052708223608134117
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lévy, Pacifique
- Hamdi, Safouane
- Guibourdenche, Jean
- Haguet, Marie Clothilde
- Bailleul, Sophie
- Lefèvre, Guillaume
Other Objects (12)
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development
Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
Klonierung und regulierbare Expression des löslichen VEGF-Rezeptors sFlt-1 in vitro
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development
Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
Klonierung und regulierbare Expression des löslichen VEGF-Rezeptors sFlt-1 in vitro
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development
Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?